Triazavirin - Amerigo Scientific

- Overview
  - Triazavirin is an antiviral drug developed against SAR-CoV-2. The action of triazavirin might be due to its ability to inhibit the Mpro protease from SARS viruses. Triazavirin has been clinically tested in the treatment of COVID-19 patients.
    
    Please contact us at for specific academic pricing.
- Properties
  - Categories
    
    Antivirals
    
    CAS Number
    
    928659-17-0
    
    Molecular Formula
    
    C5H4N6O3S·Na·2H2O
    
    Molecular Weight
    
    287.21 g/mol
    
    Note
    
    There is no hazardous surcharge associated with this product.
    There is no special packaging charge associated with this product.
    
    * For research use only. Not for human or veterinary use
- Reference
  - Wu et al (2020). Efficacy and Safety of Triazavirin Therapy for Coronavirus Disease 2019: A Pilot Randomized Controlled Trial. Engineering (Beijing, China), 6(10):1185–1191.
    Shahab et al (2021). Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study. Current Molecular Medicine.